Male Fertility Male Factor Treatment

Molecular Remodeling of the Sperm Proteome Following Varicocele Sclero-Embolization: Implications for Semen Quality Improvement

Milardi D, Vergani E, Mancini F, Di Nicuolo F, Teveroni E, Vodola EP, Oliva A, Grande G, Cina A, Iezzi R, Cicchinelli M, Iavarone F, Baroni S, Ferlin A, Urbani A, Pontecorvi A

Published July 15, 2025 Proteomes
DOI 10.3390/proteomes13030034 PMID 40700278 PMC PMC12286009

RRM Academy Synopsis

Sperm proteins shifted after varicocele treatment in five men

In a five-man case series, sperm proteins shifted after varicocele sclero-embolization in men whose semen improved. Sperm samples came from before treatment and at 3 and 6 months. Seven proteins seen only before treatment were gone afterward. Fifty-five appeared at both follow-ups.

Study at a glance, case series of five men: Sperm proteins shifted after varicocele treatment in five men
Study at a glance, case series of five men: Sperm proteins shifted after varicocele treatment in five men. Source: Milardi D et al., 2025, PMID 40700278.

Key Findings

  • Five men with left grade III or IV varicocele gave samples before and after treatment. Total motile sperm count rose more than 50% in each, at 3 months, 6 months, or both.
  • Pooled sperm samples held 2204 proteins before treatment, 2240 at 3 months and 2234 at 6 months.
  • Seven proteins appeared only before treatment, including stathmin, IFT20, selenide and ADAM21. Fifty-five appeared only after treatment, at both 3 and 6 months, including selenoprotein P and GPX3.
  • Across both follow-ups, 115 proteins rose and 33 fell. Thioredoxin (TXN) and PRDX3 rose; histone H3.1 and the autophagy protein ATG9 fell.
  • Western blot samples from three or four men per time point showed an overall rise in antioxidant proteins, significant for TXN. In that test, histone H2B fell significantly at 6 months.

Interpretation

This case series followed five men with varicocele through sclero-embolization, tracking sperm protein changes alongside the semen gains. Proteins tied to antioxidant defense rose. Histones and an autophagy protein fell. The authors note the samples were pooled across the group. The findings support larger studies of this protein signature in varicocele treatment.

RRM Context

Restorative reproductive medicine looks for a cause in both partners. The paper names varicocele as one of the primary treatable causes of male infertility. The study adds a molecular picture of sperm in men whose semen improved after treatment.

Abstract

Background

Varicocele is a common condition involving the dilation of veins in the scrotum, often linked to male infertility and testicular dysfunction. This study aimed to elucidate the molecular effects of successful varicocele treatment on sperm proteomes following percutaneous sclero-embolization.

Methods

High-resolution tandem mass spectrometry was performed for proteomic profiling of pooled sperm lysates from five patients exhibiting improved semen parameters before and after (3 and 6 months) varicocele sclero-embolization. Data were validated by Western blot analysis.

Results

Seven proteins were found exclusively in varicocele patients before surgery-such as stathmin, IFT20, selenide, and ADAM21-linked to inflammation and oxidative stress. After sclero-embolization, 55 new proteins emerged, including antioxidant enzymes like selenoprotein P and GPX3. Thioredoxin (TXN) and peroxiredoxin (PRDX3) were upregulated, indicating restoration of key antioxidant pathways. Additionally, the downregulation of some histones and the autophagy-related protein ATG9A suggests a shift toward an improved chromatin organization and a healthier cellular environment post-treatment.

Conclusions

Varicocele treatment that improves sperm quality and fertility parameters leads to significant proteome modulation. These changes include reduced oxidative stress and broadly restored sperm maturation. Despite the limited patient cohort analyzed, these preliminary findings provide valuable insights into how varicocele treatment might enhance male fertility and suggest potential biomarkers for improved male infertility treatment strategies.

Topics

By this author

Related research

Male Fertility › Male Factor Treatment › Surgical Management
Domenico Milardi, Edoardo Vergani, Francesca Mancini, Fiorella Di Nicuolo, Emanuela Teveroni, Emanuele Pierpaolo Vodola, Alessandro Oliva, Giuseppe Grande, Alessandro Cina, Roberto Iezzi, Michela Cicchinelli, Federica Iavarone, Silvia Baroni, Alberto Ferlin, Andrea Urbani, Alfredo Pontecorvi
D Milardi, E Vergani, F Mancini, F Nicuolo, E Teveroni, E Vodola, A Oliva, G Grande, A Cina, R Iezzi, M Cicchinelli, F Iavarone, S Baroni, A Ferlin, A Urbani, A Pontecorvi
PMID 40700278 40700278 DOI 10.3390/proteomes13030034 10.3390/proteomes13030034 Milardi et al. 2025, Milardi 2025